New-Onset Vitiligo and Change in Disease Status Following COVID-19 Vaccination and COVID-19 Infection—An Online Survey

Raaisa Islam; John Frew; Cindy Kok; Monisha Gupta

doi:10.1111/ajd.70027

New-Onset Vitiligo and Change in Disease Status Following COVID-19 Vaccination and COVID-19 Infection—An Online Survey

Raaisa Islam
, John Frew
, Cindy Kok
, Monisha Gupta

The Skin Hospital
The University of Sydney
Liverpool Hospital
Ingham Institute of Applied Medical Research
University of New South Wales
Department of Dermatology

Research output: Contribution to journal › Article › peer-review

Abstract

This study aimed to identify the proportion of patients with vitiligo reporting new-onset disease or changes in disease status following COVID-19 vaccination or infection using an online survey. Among 114 respondents, over half reported no new-onset vitiligo or a change in vitiligo status following COVID-19 vaccination or infection; however, a sizeable minority reported worsening of vitiligo, smaller numbers reported new-onset disease, and few reported improvement. Larger studies are needed to clarify whether these associations are coincidental or reflect underlying pathological processes.

Original language	English
Journal	Australasian Journal of Dermatology
DOIs	https://doi.org/10.1111/ajd.70027
Publication status	E-pub ahead of print (In Press) - 2025

Bibliographical note

Publisher Copyright:
© 2025 The Australasian College of Dermatologists.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

2019-nCoV vaccine mRNA-1273
BNT162 vaccine
ChAdOx1 nCoV-19
COVID-19
COVID-19 vaccines
SARS-CoV-2
vitiligo

Access to Document

10.1111/ajd.70027

Cite this

@article{8f3894b775a449f0af0f14b08de33305,

title = "New-Onset Vitiligo and Change in Disease Status Following COVID-19 Vaccination and COVID-19 Infection—An Online Survey",

abstract = "This study aimed to identify the proportion of patients with vitiligo reporting new-onset disease or changes in disease status following COVID-19 vaccination or infection using an online survey. Among 114 respondents, over half reported no new-onset vitiligo or a change in vitiligo status following COVID-19 vaccination or infection; however, a sizeable minority reported worsening of vitiligo, smaller numbers reported new-onset disease, and few reported improvement. Larger studies are needed to clarify whether these associations are coincidental or reflect underlying pathological processes.",

keywords = "2019-nCoV vaccine mRNA-1273, BNT162 vaccine, ChAdOx1 nCoV-19, COVID-19, COVID-19 vaccines, SARS-CoV-2, vitiligo",

author = "Raaisa Islam and John Frew and Cindy Kok and Monisha Gupta",

note = "Publisher Copyright: {\textcopyright} 2025 The Australasian College of Dermatologists.",

year = "2025",

doi = "10.1111/ajd.70027",

language = "English",

journal = "Australasian Journal of Dermatology",

issn = "0004-8380",

publisher = "John Wiley and Sons Inc",

}

TY - JOUR

T1 - New-Onset Vitiligo and Change in Disease Status Following COVID-19 Vaccination and COVID-19 Infection—An Online Survey

AU - Islam, Raaisa

AU - Frew, John

AU - Kok, Cindy

AU - Gupta, Monisha

PY - 2025

Y1 - 2025

N2 - This study aimed to identify the proportion of patients with vitiligo reporting new-onset disease or changes in disease status following COVID-19 vaccination or infection using an online survey. Among 114 respondents, over half reported no new-onset vitiligo or a change in vitiligo status following COVID-19 vaccination or infection; however, a sizeable minority reported worsening of vitiligo, smaller numbers reported new-onset disease, and few reported improvement. Larger studies are needed to clarify whether these associations are coincidental or reflect underlying pathological processes.

AB - This study aimed to identify the proportion of patients with vitiligo reporting new-onset disease or changes in disease status following COVID-19 vaccination or infection using an online survey. Among 114 respondents, over half reported no new-onset vitiligo or a change in vitiligo status following COVID-19 vaccination or infection; however, a sizeable minority reported worsening of vitiligo, smaller numbers reported new-onset disease, and few reported improvement. Larger studies are needed to clarify whether these associations are coincidental or reflect underlying pathological processes.

KW - 2019-nCoV vaccine mRNA-1273

KW - BNT162 vaccine

KW - ChAdOx1 nCoV-19

KW - COVID-19

KW - COVID-19 vaccines

KW - SARS-CoV-2

KW - vitiligo

UR - https://www.scopus.com/pages/publications/105025666105

U2 - 10.1111/ajd.70027

DO - 10.1111/ajd.70027

M3 - Article

C2 - 41431160

AN - SCOPUS:105025666105

SN - 0004-8380

JO - Australasian Journal of Dermatology

JF - Australasian Journal of Dermatology

ER -

New-Onset Vitiligo and Change in Disease Status Following COVID-19 Vaccination and COVID-19 Infection—An Online Survey

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this